These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18501763)

  • 1. Pharmacokinetics and pharmacodynamics in the critically ill child.
    Zuppa AF; Barrett JS
    Pediatr Clin North Am; 2008 Jun; 55(3):735-55, xii. PubMed ID: 18501763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients.
    Peeters MY; Bras LJ; DeJongh J; Wesselink RM; Aarts LP; Danhof M; Knibbe CA
    Clin Pharmacol Ther; 2008 Mar; 83(3):443-51. PubMed ID: 17687274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children.
    Zuppa AF; Adamson PC; Mondick JT; Davis LA; Maka DA; Narayan M; Nicholson C; Patel D; Collison KR; Barrett JS
    J Clin Pharmacol; 2005 Nov; 45(11):1305-12. PubMed ID: 16239364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered pharmacology in the Intensive Care Unit patient.
    Zagli G; Tarantini F; Bonizzoli M; Di Filippo A; Peris A; De Gaudio AR; Geppetti P
    Fundam Clin Pharmacol; 2008 Oct; 22(5):493-501. PubMed ID: 18684127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss.
    Arroliga AC; Guntupalli KK; Beaver JS; Langholff W; Marino K; Kelly K
    Crit Care Med; 2009 Apr; 37(4):1299-307. PubMed ID: 19242343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
    Roberts DJ; Hall RI
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing for children: issues in pediatric pharmacology.
    Niederhauser VP
    Nurse Pract; 1997 Mar; 22(3):16-8, 23, 26-8 passim. PubMed ID: 9078512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens.
    Scaglione F; Paraboni L
    Int J Antimicrob Agents; 2008 Oct; 32(4):294-301. PubMed ID: 18621508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Personalised pharmacotherapy in intensive care unit patients].
    Bellmann R
    Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics in critically ill patients.
    Varghese JM; Roberts JA; Lipman J
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):472-8. PubMed ID: 20489605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations.
    Papadopoulos J; Smithburger PL
    Crit Care Med; 2010 Jun; 38(6 Suppl):S126-35. PubMed ID: 20502166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use density in critically ill children and newborns: analysis of various methodologies.
    Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
    Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug dosing considerations for the critically ill patient with liver disease.
    Lin S; Smith BS
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):335-40. PubMed ID: 20691384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of drug metabolism in critically ill animals.
    Hackett ES; Gustafson DL
    Vet Clin North Am Small Anim Pract; 2011 Jul; 41(4):805-15, vii. PubMed ID: 21757094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Principles and perspectives of clinical pharmacology].
    Kaufmann W
    Klin Wochenschr; 1991; 69 Suppl 26():8-12. PubMed ID: 1813734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.
    Ross EL; Heizer J; Mixon MA; Jorgensen J; Valdez CA; Czaja AS; Reiter PD
    Am J Health Syst Pharm; 2015 Apr; 72(7):542-56. PubMed ID: 25788508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin therapy on intensive care should not be too intensive].
    Girbes AR; Beishuizen A
    Ned Tijdschr Geneeskd; 2009; 153():A609. PubMed ID: 19785880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric critical illness hyperglycemia: risk factors associated with development and severity of hyperglycemia in critically ill children.
    Preissig CM; Rigby MR
    J Pediatr; 2009 Nov; 155(5):734-9. PubMed ID: 19628220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The endocrinology of the critically ill].
    Gjedsted J; Larsen KM; Hansen TK
    Ugeskr Laeger; 2007 Feb; 169(8):695-6. PubMed ID: 17313918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.